VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)

$0.6241 -0.0126 (-1.979%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 71

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) News Sources

Vistagen to Participate in Upcoming Investor Conferences

03-03-2026

yahoo.com

Vistagen Receives FDA "Study May Proceed" Letter Under its Refisolone IND Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) due to Menopause

22-04-2026

yahoo.com

Vistagen Announces Completion of Last Patient Visit in PALISADE-4 Phase 3 Public Speaking Challenge Study of Fasedienol for Acute Treatment of Social Anxiety Disorder

08-05-2026

yahoo.com

Vistagen Announces Preliminary Positive Data in Ongoing Open-Label Extension Portion of PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

12-05-2026

yahoo.com

Vistagen to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

14-05-2026

yahoo.com

Compugen (CGEN) Reports Q1 Loss, Lags Revenue Estimates

18-05-2026

yahoo.com

Is Vistagen Therapeutics, Inc. (VTGN) a Breakout Anxiety Drug Stock After New Phase 3 Extension Results?

19-05-2026

yahoo.com

Vistagen Appoints Angel S. Angelov, MD, MBA, as Chief Medical Officer

19-05-2026

yahoo.com

Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Misses Revenue Estimates

20-05-2026

yahoo.com

Vistagen to Participate in Jefferies 2026 Global Healthcare Conference

27-05-2026

yahoo.com

VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) Sentiment Trend

0 25 50 75 100 91 85 82 89 89 2 91 87 2 90 03-03-2026 22-04-2026 08-05-2026 12-05-2026 14-05-2026 18-05-2026 19-05-2026 20-05-2026 27-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) FAQs

toggle

What is the current price of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?

The current price of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is $0.6241.


toggle

VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) absolute price change since previous trading day?

The absolute price change of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) since the previous trading day is $-0.0126.


toggle

VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) percentage price change since previous trading day?

The percentage price change of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) since the previous trading day is -1.979%.


toggle

What is the most recent average sentiment score for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?

The most recent average sentiment score for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is 71 out of 100.


toggle

What is the most recent average sentiment for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?

The most recent sentiment for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is .


SEC-8K** Filing Available For VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.